Evidence map›Paper›PMID 39806144›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Investigating Complexin-Membrane Interactions Using NMR and Optical Methods.

Emily M Grasso, David Eliezer

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily M GrassoDepartment of Biochemistry, Weill Cornell Medicine, New York, NY, USA.
David EliezerDepartment of Biochemistry, Weill Cornell Medicine, New York, NY, USA. dae2005@med.cornell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complexins are a family of small presynaptic proteins that regulate neurotransmitter release at nerve terminals and are highly conserved in evolution. While direct interactions with SNARE proteins are critical for all complexin functions, binding of their disordered C-terminal domains (CTD) to membranes, especially to synaptic vesicle membranes, is essential for the ability of complexin to inhibit vesicle release. Furthermore, while some complexin CTDs possess an endogenous affinity for membranes, other complexin isoforms are subject to lipidation at their C-termini, which is presumed to confer additional membrane binding. Therefore, an in depth understanding of complexin-membrane interactions is required to elucidate the mechanistic basis for their inhibitory activity. Here we describe protocols for characterizing complexin-membrane interactions using solution state nuclear magnetic resonance (NMR) spectroscopy as well as single molecule total-internal reflection fluorescence (TIRF) methods, along with protocols for generating isotopically labeled samples of unmodified and farnesylated complexins and for characterizing synthetic lipid vesicles using dynamic light scattering (DLS).

Indexed as

Adaptor Proteins, Vesicular TransportCell MembraneNerve Tissue ProteinsDynamic Light ScatteringHumansMagnetic Resonance SpectroscopyProtein BindingSynaptic VesiclesAdaptor Proteins, Vesicular Transportcomplexin INerve Tissue ProteinsComplexinDLSFluorescence microscopyLipid bindingNMR

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.